Advertisement

Atrial Fibrillation, a Treatable Disease?

  • J. H. Kingma
  • N. M. van Hemel
  • K. I. Lie

Part of the Developments in Cardiovascular Medicine book series (DICM, volume 139)

Table of contents

  1. Front Matter
    Pages i-xix
  2. Concepts and Clinics of Atrial Fibrillation

    1. Norbert M. van Hemel, Jacques M. T. de Bakker, Anand Ramdat Misier, Jo A. M. Defauw
      Pages 1-22
    2. Gérard M. Guiraudon, Colette M. Guiraudon
      Pages 23-40
    3. Colette M. Guiraudon, Nicolette M. Ernst, Gérard M. Guiraudon, Raymond Yee, George J. Klein
      Pages 41-57
  3. Recent Advances in the Treatment of Paroxysmal Atrial Fibrillation and Flutter

    1. Maarten J. Suttorp, Emile R. Jessurun, J. Herre Kingma
      Pages 87-103
    2. Harry J. G. M. Crijns, A. T. Marcel Gosselink, Isabelle C. van Gelder, Ans C. P. Wiesfeld, Maarten P. van den Berg, Ype S. Tuininga et al.
      Pages 105-148
    3. Loraine Lie-A-Huen, J. Herre Kingma
      Pages 149-157
    4. Andrew M. Tonkin, Jonathan M. Kalman, Norma Gilli
      Pages 159-165
    5. Jo A. M. Defauw, Norbert M. van Hemel, J. Herre Kingma, Wybren Jaarsma, Freddy E. E. Vermeulen, Jacques M. T. de Bakker et al.
      Pages 167-181
  4. Why Aggressive Therapy in Atrial Fibrillation?

    1. Hein J. J. Wellens, Luz-Maria Rodriquez, Joep L. R. M. Smeets, Emile C. Cheriex, Frans Pieters, Karel den Dulk
      Pages 183-193
    2. Francis D. Murgatroyd, A. John Camm
      Pages 195-210
    3. Jonathan M. Kalman, Muhammad Munawar, Anthony Yapanis, Laurence G. Howes, William J. Louis, Brian F. Buxton et al.
      Pages 211-225
    4. Maarten J. Suttorp, J. Herre Kingma, Norbert M. van Hemel, Jo A. M. Defauw, Freddy E. E. Vermeulen, Sjef M. P. G. Ernst
      Pages 227-236
    5. A. T. Marcel Gosselink, Harry J. G. M. Crijns, Kong I. Lie
      Pages 237-257
    6. J. Herre Kingma, Maarten J. Suttorp, Willem P. Beukema
      Pages 271-284
  5. Back Matter
    Pages 285-303

About this book

Introduction

The attack of atrial fibrillation experienced by President Bush of the United States attracted more attention from the general public to atrial fibrillation than ever before. Also, there is a growing body of knowledge of the pathophysiologic mechanism, the pathology and epidemiology, and especially of the thrombo-embolic complications of this arrhythmia, which is responsible for a renewed interest of the clinician in this very common human arrhythmia. These new perspectives on atrial fibrillation were presented during a conference on `Atrial Fibrillation, a Treatable Disease?', organized on May 7, 1992, in Amsterdam, the Netherlands.
Atrial fibrillation is not the prerogative of the cardiologist only. Many practitioners from other areas in health care, in particular general physicians, internists and neurologists, are faced with this arrhythmia and its untoward consequences. This book bridges the gap between theory, experiment and the clinic. Emphasis is therefore on the selection of the optimal approach, including pharmacotherapy, catheter ablation, pacemaker and surgical therapy, based on the current scientific insights in the mechanism and prevention of atrial fibrillation.

Keywords

Ablation Bypass anatomy atrial fibrillation embolism

Editors and affiliations

  • J. H. Kingma
    • 1
  • N. M. van Hemel
    • 1
  • K. I. Lie
    • 2
  1. 1.Department of CardiologySt. Antonius HospitalNieuwegeinThe Netherlands
  2. 2.Department of Cardiology, Thorax-centerUniversity Hospital GroningenGroningenThe Netherlands

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-011-1816-3
  • Copyright Information Kluwer Academic Publishers 1992
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-94-010-4801-9
  • Online ISBN 978-94-011-1816-3
  • Series Print ISSN 0166-9842
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology